---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-031301"
form_type: "8-K"
ticker: "SMTI"
cik: "0000714256"
company_name: "Sanara MedTech Inc."
filed_at: "2024-08-12T23:59:59+00:00"
generated_at: "2026-05-31T10:12:29.256465+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sanara Q2 revenue up 28% to record $20.2M; net loss widens to $3.5M

## Summary
- Revenue $20.2M, +28% YoY; eleventh consecutive record revenue quarter.
- Net loss $3.5M vs $1.9M; Adjusted EBITDA $0.6M vs ($0.3M).
- Secured $55M non-dilutive term loan from CRG; $15M drawn, up to $39.8M additional.
- New GPO agreement adds over 1,000 contracted facilities; 300+ distributors, +70 since Jan.
- Appointed Jake Waldrop as COO and Tyler Palmer as Chief Corporate Development & Strategy Officer.

## SEC filing metadata
- accession: 0001493152-24-031301
- form_type: 8-K
- ticker: SMTI
- cik: 0000714256
- company_name: Sanara MedTech Inc.
- filed_at: 2024-08-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/714256/000149315224031301/0001493152-24-031301-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/714256/000149315224031301/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-031301
- JSON: https://secwatch.observer/filing/0001493152-24-031301.json
- Plain text: https://secwatch.observer/filing/0001493152-24-031301.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.